Publications by authors named "Jeffrey Olearczyk"

Claim this Profile
T
Targeting of hepatic angiotensinogen using chemically modified siRNAs results in significant and sustained blood pressure lowering in a rat model of hypertension.
Jeffrey Olearczyk, Sheng Gao, Marianne Eybye, Satyasri Yendluri, Lori Andrews

Hypertens Res· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.
Jeffrey J Olearczyk, Jeffrey E Quigley, Bradford C Mitchell, Tatsuo Yamamoto, In-Hae Kim

Clin Sci (Lond)· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemokine receptor 2b inhibition provides renal protection in angiotensin II - salt hypertension.
Ahmed A Elmarakby, Jeffrey E Quigley, Jeffrey J Olearczyk, Aarthi Sridhar, Anthony K Cook

Hypertension· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normalization of the ovarian cancer microenvironment by SPARC.
Neveen Said, Matthew J Socha, Jeffrey J Olearczyk, Ahmed A Elmarakby, John D Imig

Mol Cancer Res· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substituted adamantyl-urea inhibitors of the soluble epoxide hydrolase dilate mesenteric resistance vessels.
Jeffrey J Olearczyk, Mary B Field, In-Hae Kim, Christophe Morisseau, Bruce D Hammock

J Pharmacol Exp Ther· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.
John D Imig, Xueying Zhao, Constantine Z Zaharis, Jeffrey J Olearczyk, David M Pollock

Hypertension· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NO inhibits signal transduction pathway for ATP release from erythrocytes via its action on heterotrimeric G protein Gi.
Jeffrey J Olearczyk, Alan H Stephenson, Andrew J Lonigro, Randy S Sprague

Am J Physiol Heart Circ Physiol· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nitric oxide inhibits ATP release from erythrocytes.
Jeffrey J Olearczyk, Mary L Ellsworth, Alan H Stephenson, Andrew J Lonigro, Randy S Sprague

J Pharmacol Exp Ther· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterotrimeric G protein Gi is involved in a signal transduction pathway for ATP release from erythrocytes.
Jeffrey J Olearczyk, Alan H Stephenson, Andrew J Lonigro, Randy S Sprague

Am J Physiol Heart Circ Physiol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extracellular ATP signaling in the rabbit lung: erythrocytes as determinants of vascular resistance.
Randy S Sprague, Jeffrey J Olearczyk, Dana M Spence, Alan H Stephenson, Robert W Sprung

Am J Physiol Heart Circ Physiol· August 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis